Identifying tinnitus-related genes based on a side-effect network analysis

CPT: Pharmacometrics and Systems Pharmacology

Volumn 3, Issue 1, 2014, Pages

  Elgoyhen, A B ^a,b   Langguth, B ^c   Nowak, W ^b   Schecklmann, M ^c   De Ridder, D ^d   Vanneste, S ^e  

^a INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NEUROLEPTIC AGENT; OPIATE; SALICYLIC ACID;

ANALYSIS; ARTICLE; DATA BASE; DEPRESSION; GENE IDENTIFICATION; GENE REGULATORY NETWORK; HEARING IMPAIRMENT; HUMAN; LOUDNESS RECRUITMENT; NERVOUS SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SIDE EFFECT NETWORK ANALYSIS; TINNITUS;

EID: 84903693474     PISSN: None     EISSN: 21638306     Source Type: Journal    
DOI: 10.1038/psp.2013.75     Document Type: Article

References (50)

1. Jastreboff, P.J. Phantom auditory perception (tinnitus): mechanisms of generation and perception. Neurosci. Res. 8, 221-254 (1990).
2. Shargorodsky, J., Curhan, G.C. & Farwell, W.R. Prevalence and characteristics of tinnitus among US adults. Am. J. Med. 123, 711-718 (2010).
3. Nondahl, D.M. et al. Generational differences in the reporting of tinnitus. Ear Hear. 33, 640-644 (2012).
4. Langguth, B., Kreuzer, P.M., Kleinjung, T. & De Ridder, D. Tinnitus: causes and clinical management. Lancet Neurol. 12, 920-930 (2013).
5. De Ridder, D., Elgoyhen, A.B., Romo, R. & Langguth, B. Phantom percepts: tinnitus and pain as persisting aversive memory networks. Proc. Natl. Acad. Sci. USA 108, 8075-8080 (2011).
6. Kupfer, D.J., Frank, E. & Phillips, M.L. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 379, 1045-1055 (2012).
7. Northoff, G. Gene, brains, and environment-genetic neuroimaging of depression. Curr. Opin. Neurobiol. 23, 133-142 (2013).
8. van Os, J. & Kapur, S. Schizophrenia. Lancet 374, 635-645 (2009).
9. Elgoyhen, A.B. & Langguth, B. Pharmacological approaches to the treatment of tinnitus. Drug Discov. Today 15, 300-305 (2010).
10. Barabási, A.L. & Oltvai, Z.N. Network biology: understanding the cell's functional organization. Nat. Rev. Genet. 5, 101-113 (2004).
11. Hopkins, A.L. Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 4, 682-690 (2008).
12. Loging, W., Harland, L. & Williams-Jones, B. High-throughput electronic biology: mining information for drug discovery. Nat. Rev. Drug Discov. 6, 220-230 (2007).
13. Kuhn, M., Campillos, M., González, P., Jensen, L.J. & Bork, P. Large-scale prediction of drug-target relationships. FEBS Lett. 582, 1283-1290 (2008).
14. Paolini, G.V., Shapland, R.H., van Hoorn, W.P., Mason, J.S. & Hopkins, A.L. Global mapping of pharmacological space. Nat. Biotechnol. 24, 805-815 (2006).
15. Yildirim, M.A., Goh, K.I., Cusick, M.E., Barabási, A.L. & Vidal, M. Drug-target network. Nat. Biotechnol. 25, 1119-1126 (2007).
16. Keiser, M.J. et al. Predicting new molecular targets for known drugs. Nature 462, 175-181 (2009).
17. Elgoyhen, A.B., Langguth, B., Vanneste, S. & De Ridder, D. Tinnitus: network pathophysiology-network pharmacology. Front. Syst. Neurosci. 6, 1 (2012).
18. Campillos, M., Kuhn, M., Gavin, A.C., Jensen, L.J. & Bork, P. Drug target identification using side-effect similarity. Science 321, 263-266 (2008).
19. Kuhn, M., Campillos, M., Letunic, I., Jensen, L.J. & Bork, P. A side effect resource to capture phenotypic effects of drugs. Mol. Syst. Biol. 6, 343 (2010).
20. Roth, B.L., Sheffler, D.J. & Kroeze, W.K. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat. Rev. Drug Discov. 3, 353-359 (2004).
21. Baguley, D.M. Hyperacusis. J. R. Soc. Med. 96, 582-585 (2003).
22. Dauman, R. & Bouscau-Faure, F. Assessment and amelioration of hyperacusis in tinnitus patients. Acta Otolaryngol. 125, 503-509 (2005).
23. Langguth, B., Landgrebe, M., Kleinjung, T., Sand, G.P. & Hajak, G. Tinnitus and depression. World J. Biol. Psychiatry 12, 489-500 (2011).
24. Lounkine, E. et al. Large-scale prediction and testing of drug activity on side-effect targets. Nature 486, 361-367 (2012).
25. Chen, G.D., Stolzberg, D., Lobarinas, E., Sun, W., Ding, D. & Salvi, R. Salicylate-induced cochlear impairments, cortical hyperactivity and re-tuning, and tinnitus. Hear. Res. 295, 100-113 (2013).
26. Santos-Sacchi, J., Song, L., Zheng, J. & Nuttall, A.L. Control of mammalian cochlear amplification by chloride anions. J. Neurosci. 26, 3992-3998 (2006).
27. Noreña, A.J., Moffat, G., Blanc, J.L., Pezard, L. & Cazals, Y. Neural changes in the auditory cortex of awake guinea pigs after two tinnitus inducers: salicylate and acoustic trauma. Neuroscience 166, 1194-1209 (2010).
28. Wallhäusser-Franke, E., Mahlke, C., Oliva, R., Braun, S., Wenz, G. & Langner, G. Expression of c-fos in auditory and non-auditory brain regions of the gerbil after manipulations that induce tinnitus. Exp. Brain Res. 153, 649-654 (2003).
29. Eggermont, J.J. & Roberts, L.E. The neuroscience of tinnitus. Trends Neurosci. 27, 676-682 (2004).
30. Saint, D.A. The cardiac persistent sodium current: an appealing therapeutic target? Br. J. Pharmacol. 153, 1133-1142 (2008).
31. Reyes, S.A. et al. Brain imaging of the effects of lidocaine on tinnitus. Hear. Res. 171, 43-50 (2002).
32. Hartmann, H.A., Colom, L.V., Sutherland, M.L. & Noebels, J.L. Selective localization of cardiac SCN5A sodium channels in limbic regions of rat brain. Nat. Neurosci. 2, 593-595 (1999).
33. Wu, L., Nishiyama, K., Hollyfield, J.G. & Wang, Q. Localization of Nav1.5 sodium channel protein in the mouse brain. Neuroreport 13, 2547-2551 (2002).
34. White, J.A., Alonso, A. & Kay, A.R. A heart-like Na+ current in the medial entorhinal cortex. Neuron 11, 1037-1047 (1993).
35. Hoehn, K., Watson, T.W. & MacVicar, B.A. A novel tetrodotoxin- insensitive, slow sodium current in striatal and hippocampal neurons. Neuron 10, 543-552 (1993).
36. Bartolomé, M.V. & Gil-Loyzaga, P. Serotonergic innervation of the inner ear: is it involved in the general physiological control of the auditory receptor? Int. Tinnitus J. 11, 119-125 (2005).
37. Brown, P. & Molliver, M.E. Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity. J. Neurosci. 20, 1952-1963 (2000).
38. Guillery, R.W. & Sherman, S.M. Thalamic relay functions and their role in corticocortical communication: generalizations from the visual system. Neuron 33, 163-175 (2002).
39. Rauschecker, J.P., Leaver, A.M. & Mühlau, M. Tuning out the noise: limbic-auditory interactions in tinnitus. Neuron 66, 819-826 (2010).
40. Wright, J.W. & Harding, J.W. The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases. Pflugers Arch. 465, 133-151 (2013).
41. Phillips, M.I., Shen, L., Richards, E.M. & Raizada, M.K. Immunohistochemical mapping of angiotensin AT1 receptors in the brain. Regul. Pept. 44, 95-107 (1993).
42. Kaltenbach, J.A. The dorsal cochlear nucleus as a contributor to tinnitus: mechanisms underlying the induction of hyperactivity. Prog. Brain Res. 166, 89-106 (2007).
43. Derad, I., Pietrowsky, R., Dodt, C., Fehm, H.L. & Born, J. Enhanced psychophysiological signs of attention after angiotensin-converting enzyme inhibition by captopril. Psychophysiology 33, 295-301 (1996).
44. Noreña, A.J. An integrative model of tinnitus based on a central gain controlling neural sensitivity. Neurosci. Biobehav. Rev. 35, 1089-1109 (2011).
45. Hébert, S., Fournier, P. & Noreña, A. The auditory sensitivity is increased in tinnitus ears. J. Neurosci. 33, 2356-2364 (2013).
46. Marriage, J. & Barnes, N.M. Is central hyperacusis a symptom of 5-hydroxytryptamine (5-HT) dysfunction? J. Laryngol. Otol. 109, 915-921 (1995).
47. Noreña, A.J. & Eggermont, J.J. Changes in spontaneous neural activity immediately after an acoustic trauma: implications for neural correlates of tinnitus. Hear. Res. 183, 137-153 (2003).
48. Gu, J.W., Halpin, C.F., Nam, E.C., Levine, R.A. & Melcher, J.R. Tinnitus, diminished sound-level tolerance, and elevated auditory activity in humans with clinically normal hearing sensitivity. J. Neurophysiol. 104, 3361-3370 (2010).
49. Knox, C. et al. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 39, D1035-D1041 (2011).
50. Smoot, M.E., Ono, K., Ruscheinski, J., Wang, P.L. & Ideker, T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27, 431-432 (2011).